and patient engagement: learning from the venous ... · and patient engagement: learning from the...
TRANSCRIPT
Practice, Policy, Public Reporting,and Patient Engagement:Learning from the Venous
Thromboembolism ExampleElliott R. Haut, MD, PhD, FACS
Vice Chair of Quality and Safety,Associate Professor of Surgery & ACCM &
Emergency Medicine & Health Policy / Management
10/10/17 Center for Health Services and Outcomes Research (CHSOR) Seminar
@elliotthaut
• Deep Vein Thrombosis (DVT) • Pulmonary Embolism (PE)
What is Venous Thromboembolism (VTE) ?
What Causes Venous Thromboembolism (VTE)?
Hypercoaguability
Rudolf Virchow (1821-1902)
Why focus on VTE?
• VTE is common– 350,000 to 600,000
Americans suffer DVT and/or PE each year
http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf
Why focus on VTE?
• VTE is Deadly– >100,000 deaths per year
• More deaths than combined from– Breast Cancer– Motor Vehicle Collisions– AIDS
http://www.surgeongeneral.gov/topics/deepvein/calltoaction/call-to-action-on-dvt-2008.pdf
Johns Hopkins DVT Symposium 2009
Risk Factors for VTE
• Age• Cancer• Chemotherapy• Previous DVT/PE• Trauma• Major surgery• Hospitalization• Thrombophilia• Pregnancy
• Hormone therapy• Family history of VTE• Recent Stroke• Cardiac disease• Respiratory disease• Infection• Immobility > 3 days• Varicose veins• Obesity
Why focus on VTE?
• Increases cost– Increased per patient, per event cost
estimates vary• $11,930 (Spyropoulos)• $15,941 (Lefebvre)
– Annual direct costs > $250 million annually for venous stasis/ulcer alone
• $7-10 billion total yearly cost the USSpyropoulos 2002, Lefebvre 2012, Ashrani 2009, Heit 2001, Grosse 2016
Why focus on VTE?
• VTE is (mostly) preventable
VTE Should NOT be Considered a “Never Event”
• Not ALL events are preventable
• VTE occurs even in patients receiving best practice prophylaxis
• 8 RCTs of VTE Prophylaxis in Joint Replacement Surgery (4 TKA, 4 THR)– 0.3%-2.5% Symptomatic VTE
Streiff & Haut, JAMA 2009
Evidence BasedVTE Prophylaxis Guidelines
• American College of Chest Physicians (ACCP)
• Eastern Association for the Surgery of Trauma (EAST)
• American Academy of Orthopedic Surgeons (AAOS)
• American College of Obstetricians and Gynecologists (ACOG)
• American College of Physicians (ACP)
DVT Prophylaxis is Vastly Underutilized!
• 68,183 patients• 358 hospitals in 32 countries• Prophylaxis
• 58.5 % compliance - surgical patients• 39.5 % compliance - medical patientsCohen, Lancet 2008
DVT: Advancing Awareness to Protect Patient Lives
American Public Health Association (APHA)White Paper 2003
Agency for Healthcare Research and Quality (AHRQ)
www.ahrq.gov
http://www.ahrq.gov/research/findings/evidence-based-reports/services/quality/ptsafetysum.pdf
• “Strategies to increase appropriate prophylaxis for VTE” included on list of top 10 “Strongly Encouraged Patient Safety Practices”
http://www.ahrq.gov/research/findings/evidence-based-reports/patientsftyupdate/ptsafetyIIchap28.pdf
Surveillance Bias and Public Reporting of VTE
@elliotthaut
How did I get interested in VTE?
• Adult Trauma Performance Improvement• Paraphrased letter we received• Dear Johns Hopkins Adult Trauma• You have the highest DVT rate of all
Trauma Centers in Maryland• Why?• Sincerely, Maryland Institute for
Emergency Medical Services Systems (MIEMSS)
A New Research Idea is Born
• Johns Hopkins screens aggressively• What do other trauma centers do?• Does this impact reported DVT rates?
Conflict Regarding Duplex Screening for asymptomatic DVT
• Conflicting data on efficacy and cost-effectiveness of duplex screening of asymptomatic trauma patients
• Pro: Identify DVT early allowing treatment before fatal PE
• Con: Large expense, not cost effective, harm from anticoagulation
Should we Screen High-Risk Trauma Patients for DVT?
Conflicting Guidelines
vs.
Rogers, J Trauma 2002Gould, CHEST 2012
Eastern Association for the Surgery of Trauma (EAST) Guideline
• “Serial duplex ultrasound imaging of high-risk asymptomatic trauma patients to screen for DVT may be cost-effective and decrease the incidence of PE.”
http://www.EAST.org/resources/treatment-guidelinesRogers, J Trauma 2002
American College of Chest Physicians (ACCP) Guidelines
• “For major trauma patients, we suggest that periodic surveillance with venous compression ultrasonographyshould not be performed (Grade 2C).”
Gould, CHEST 2012
0
2
4
6
8
10
0
20
40
60
80
100
Before (1995-1997) After (1999-2005) DVT
/PE
Rat
e pe
r 10
00 T
raum
a A
dmis
sion
s
Dup
lex
Rat
e pe
r 10
00 T
raum
a A
dmis
sion
s
Before Vs. After Periods
Duplex DVT PE
Single Center (JHH)- Duplex & DVT ratesBefore v. After Screening Guideline
82
0.721
* **7
p<0.0001p=0.0024Haut, J Trauma 2007
Multi-Center (NTDB)- Hospital LevelDuplex & DVT rates
• Trauma centers with higher rates of duplex ultrasound report higher DVT rates to the National Trauma Data Bank
Pierce, J Trauma 2008
The More We Look, The More We Find
Pierce, Haut, et al. J Trauma 2008
7-fold higher DVT rate at hospitals in top quartile of duplex ultrasounds
Pierce, J Trauma 2008
Hospital Screening Status is an Independent Risk Factor for DVT Reporting
Haut, J Trauma 2009
Variability in Trauma Surgeons Opinions of DVT Screening
• AAST/EAST member survey• 317 individual trauma surgeons
Haut, J Trauma 2011
A Classic Example ofSurveillance Bias
• Providers who screen more aggressively by performing more duplex ultrasounds may identify more cases of DVT and appear to provide worse quality of care than those providers who order fewer tests
Haut & Pronovost, JAMA 2011
Implications
Variability in DVT
Screening
Variability in DVT Rates
Reported
Biased DVT
Rates
Haut & Pronovost, JAMA 2011
“We’ll just use the test results anyway because it’s the only data we have”
http://dilbert.com/strips/comic/2010-11-07
Defining Preventable HarmThe VTE Example
• We suggested that “performance measures could link a process of care with adverse outcomes when defining incidences of preventable harm”
Haut & Pronovost, JAMA 2011
Preventable Harm =VTE + No Prophylaxis
We Talked
• Centers for Medicare & Medicaid Services listened
We Talked
• Financial incentives for the “meaningful use” of certified EHR technology to improve patient care
“Meaningful Use” Quality Reporting Criteria Related to VTE
•“Meaningful Use” of Electronic Health Record (EHR) Technology
–VTE1 Prophylaxis within 24 hours of arrival–VTE2 ICU VTE Prophylaxis –VTE3 Anticoagulation Overlap Therapy –VTE4 Platelet Monitoring on UFH–VTE5 VTE Discharge Instructions–VTE6 Incidence of Potentially Preventable VTE
https://www.cms.gov/EHRIncentivePrograms/30_Meaningful_Use.asp
“Meaningful Use” Definition of Potentially Preventable VTE
•VTE-6 Incidence of Potentially Preventable VTE•“This measure assesses the number of patients diagnosed with confirmed VTE during hospitalization (not present or suspected at admission) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnostic testing order date.”
Surveillance Bias in VTE Reporting in Surgery
Bilimoria, JAMA 2013
Surveillance Bias in VTE Reporting in Surgery
• 2,786 hospitals• 954,526 Medicare patients >=65 years• 11 major operations
– AAA, CABG, craniotomy, colectomy, cystectomy, esophagectomy, gastric bypass, lung resection, pancreatic resection, proctectomy, total knee arthroplasty
Bilimoria, JAMA 2013
Surveillance Bias in VTE Reporting in Surgery
Bilimoria, JAMA 2013
Public Reporting for VTE is a Moving Target
• What is the optimal approach to public reporting of VTE??
Bilimoria KY. JAMA 2015 x2 commentaries
No Association Between Hospital-Reported Perioperative VTE Prophylaxis and Outcome Ratesin Publicly Reported Data
JohnBull,JAMA-Surg 2014
• 3040 hospitals• Median prophylaxis
performance = 94.5% • The median risk-
adjusted VTE rate was 4.13 per 1000 surgical discharges
Process
Hospitalsreporting 100% perfect
VTE prophylaxis performance(n = 141)
Hospitalsin the bottom quintile
of prophylaxis performance(n = 618)
JohnBull, JAMA-Surg 2014
Nearly identical median VTE outcome rates(4.18 vs. 4.17; P = .98)
vs.
No Association Between Hospital-Reported Perioperative VTE Prophylaxis and Outcome Ratesin Publicly Reported Data
Public Reporting for VTE is a Moving Target
• In 2017, VTE-1 and VTE-2 are electronic clinical quality measures (eCQM) available for selection by hospitals to meet hospital accreditation program requirements for eCQMs.
• VTE-6 is the lone remaining measure required for chart abstracted measures.
The American College of SurgeonsInspiring Quality Tour: Lessons Learned
http://www.facs.org/quality/lessons-learned.pdf
The American College of SurgeonsInspiring Quality Tour: Lessons Learned
http://www.facs.org/quality/lessons-learned.pdf
Can a Systems Approach Improve VTE Prevention and Outcomes
@elliotthaut
What approaches can improve VTE prophylaxis ?
• “Passive dissemination of guidelines is unlikely to improve VTE prophylaxis practice.”
• “A number of active strategies used together, which incorporate some method for reminding clinicians to assess patients for DVT risk and assisting the selection of appropriate prophylaxis, are likely to result in the achievement of optimal outcomes.”
Tooher, A Systematic Review of Strategies to Improve Prophylaxisfor Venous Thromboembolism in Hospitals. Ann Surg 2005.
Improving VTE Prophylaxisat The Johns Hopkins Hospital
Streiff, BMJ 2012
Streiff, BMJ 2012
Improving VTE Prophylaxis at
The Johns
Hopkins Hospital
Paper Order Sets
Improving VTE Prophylaxisat The Johns Hopkins Hospital
• Mandatory VTE risk stratification tool into the computerized provider order entry (CPOE) system
• Advanced computerized clinical decision support (CDS)
Streiff, BMJ 2012
Parent order set
Different Order Sets have Different VTE Modules. Use is Mandatory in POE workflow.
General Surgery VTE ProphylaxisAny CONTRAINDICATIONS to
pharmacologic prophylaxis? High risk of bleeding Active bleeding
Systemic anticoagulation INR ≥ 1.5 or aPTT ratio ≥ 1.3 Platelet count < 50,000
Yes
TEDs/SCDsUse mechanical prophylaxis
until contraindication no longerpresent. Review patient status daily
Any Minor VTE risk factors? Acute Infection/Sepsis
Bed rest Central venous catheter
Estrogens/Selective estrogen receptor modulators (e.g., Tamoxifen)Inflammatory bowel disease
Moderate Risk VTE Orders
Heparin 5000 units sc q12h(Give first dose 2 hrs. pre-op
and then beginning 12-24 hours post-op)
With option to ADD TEDs/SCDs
Very high risk VTE orders Heparin 5000 units sc q8h(Give first dose 2 hrs. pre-op
and then beginning 12-24 hours post-op)
PlusTEDS/SCDs
Yes
No
Very high risk VTE ordersHeparin 5000 units sc q8h
(Give first dose 2 hrs. pre-op and thenbeginning 12-24 hours post-op)
PlusTEDS/SCD
Enoxaparin 40mg sc qDay(First dose 2 hours pre-op and then
12-24 hours post-op)(Remove epidural catheter at nadir (20-22 hrs.) of anticoagulant effect and wait at least 2 hours
after catheter removal to redose)Plus
TEDS/SCDs
No
Yes
Creatinine clearance < 30 ml/min or
unstable renal function (potential for CrCl to
Decline below 30ml/min during therapy)
Any Major VTE risk factors? Previous VTECancer
Thrombophilia Prolonged procedure (> 2 hrs.)NYHA Class III/IV Heart FailureRespiratory failure requiring mechanical ventilation
Acute Stroke with paresis (< 3 mos.) Pregnancy/post-partum (up to 6 weeks)
No
Age > 60?
Yes
Age ≥40?
No
High risk VTE orders
Heparin 5000 units sc q8h(Give first dose 2 hrs. pre-op
and then beginning 12-24 hours post-op)
With Option to add TEDS/SCD
No
Yes
No
Yes
Any CONTRAINDICATIONS topharmacologic prophylaxis? High risk of bleeding Active bleeding
Systemic anticoagulation INR ≥ 1.5 or aPTT ratio ≥ 1.3 Platelet count < 50,000
No
TEDs/SCDsUse mechanical prophylaxis
until contraindication no longerpresent. Review patient status daily
YesAny CONTRAINDICATIONS to
pharmacologic prophylaxis? High risk of bleeding Active bleeding
Systemic anticoagulation INR ≥ 1.5 or aPTT ratio ≥ 1.3 Platelet count < 50,000
Yes
No
Mandatory choice from each section for risk factors and contraindications
Benefits of the Computerized VTE Prevention System
• Puts VTE prevention into the work flow• Enables rapid, accurate risk stratification
and risk-appropriate VTE prophylaxis• Applies evidence directly to clinical care• Allows for performance monitoring/reporting
Streiff, BMJ 2012
Keys to Success
• Multidisciplinary team– Physicians, Nurses, Pharmacists, Informatics
• Leadership buy-in• Collaborate with service teams• Educate front-line providers• Measure baseline performance• Conduct ongoing performance evaluations
Streiff, BMJ 2012
Does Improving Prophylaxis Change Outcomes?
•YES
•2 examples–Johns Hopkins Trauma Surgery–Johns Hopkins Internal Medicine
Does Improving Prophylaxis Change Outcomes? The JHH Trauma Example
Haut, Arch Surg 2012
Does Improving Prophylaxis Change Outcomes? The JHH Trauma Example
• Single Center (Johns Hopkins Hospital)• Pre/Post Intervention Study• 1-year PRE vs. 3-years POST• Retrospective data collection• IRB approved
Haut, Arch Surg 2012
• Significantincrease in VTE prophylaxis
• Significant drop in preventable harm from VTE• 1.0% vs. 0.17%
(p=0.04)
Haut, Arch Surg 2012
62.2%
84.4%
Does Improving Prophylaxis Change Outcomes? The JHH Trauma Example
Does Improving Prophylaxis Change Outcomes? The JHH Medicine Example
Zeidan, Am J Hematology 2013
Zeidan, Am J Hematology 2013
• Retrospective Review (PRE v. POST)• Patients : 1,000 PRE v. 942 POST• Patients prescribed Optimal Prophylaxis
– 65.6% v. 90.1% (p<0.0001)• Patients prescribed NO prophylaxis
– 23.6% v. 4.4% (p<0.0001)
Does Improving Prophylaxis Change Outcomes? The JHH Medicine Example
Zeidan, Am J Hematology 2013
Does Improving Prophylaxis Change Outcomes? The JHH Medicine Example
Zeidan, Am J Hematology 2013
ZERO Preventable VTE –A Realistic Goal
VTE Prophylaxis-Computerized Decision Support
66www.natfonline.org
www.AHRQ.gov 2015
Improving VTE Prophylaxis Administration with Targeted Performance Feedback
@elliotthaut
The Role of Health Informatics
• Harness the power of analytics• Bringing performance data to individual
providers and units• Can competition drive improvements?
Trauma Attending & Resident Prophylaxis
Lau, JAMA-Surg 2015
42 residents at 100%
7 residents at 0%
87.7%Sept
93.3%October
96.3%November
Lau, Ann Surg 2016
Surgery Resident Feedback Improves VTE Prophylaxis
Quality Improvement can Lead to Fundable Research
• 5-year R01 grant• AHRQ• “Individualized
Performance Feedback on Venous Thromboembolism Prevention Practice”
Missed Doses of VTE Prophylaxis
@elliotthaut
A Big Assumption
• As physicians, we assume that medication orders we place are consistently delivered
• But is that truly the case?• Does prescription = administration?
Steps to Optimal Pharmacologic VTE Prophylaxis
Provider Prescription
Nurse Administration
Patient Acceptance
Do Missed VTE Prophylaxis Doses Matter?
• Methods• Retrospective analysis• 202 trauma and general surgery patients ordered
enoxaparin• Results
• Overall incidence of DVT = 15.8%• 58.9% of patients missed >=1 dose• DVT compared missed vs. no missed doses
• 23.5% vs. 4.8% (p < 0.01)
Louis, JAMA Surgery 2014
Haut, JAMA Surgery 2015
Do Missed VTE Prophylaxis Doses Matter?
• 92 VTE patients
• 39% missed >=1 dose of prophylaxis
Missed Doses of VTE Prophylaxis Medications at Johns Hopkins
• December 1, 2007 to June 30, 2008– >100,000 doses– 12% of doses not administered
• Patient refusal most frequent (~60%) documented reason
Shermock, PlosOne 2013
Shermock, PlosOne 2013
Missed Doses are Clustered Within Floors
What’s the Real Story Behind Missed Doses?
• “Hidden Barriers to Delivery of Pharmacologic Venous Thromboembolism Prophylaxis”
• Mixed methods study (quantitative/qualitative)– Quantitative Nursing survey– Qualitative observations of nurse/patient
interaction– Focus groups with nurses
Elder, Journal of Patient Safety epub 2014
What’s the Real Story Behind Missed Doses? - Quantitative
• “I have the clinical knowledge and experience to determine if it is necessary to administer DVT/PE prophylaxis injections to patients.”– AGREE 87%/79% medicine/surgery
• “Nurses use their clinical decision-making skills to determine when to omit unnecessary doses of prescribed DVT/PE prophylaxis injections for each individual patient”– AGREE 80%/50% medicine/surgery
Elder, Journal of Patient Safety epub 2014
Is VTE Prophylaxis Optional?
• “I push harder for my patients to accept heparin [prophylaxis] if they have, like, sickle cell disease, as opposed to say pneumonia or something where they are just here for [IV] antibiotics.”
• “Sometimes, if it is the middle of the night and [LDUH] is the only medication I have to give a patient, I won’t wake them up just to give VTE prophylaxis.”
Elder, Journal of Patient Safety epub 2014
The Ambulation Myth
• “We make the clinical decision all the time as to whether a patient needs VTE prophylaxis every day, based on how much the patient is ambulating.”
• “Hey Ms. R, it’s time for your heparin dose, but as long as I see you up, high-fiving me in the hallways, we can hold off for now.”
Elder, Journal of Patient Safety epub 2014
Our PCORI Project
• Preventing Venous Thromboembolism: Empowering Patients and Enabling Patient-Centered Care via Health Information Technology
http://www.pcori.org/research-in-action/improving-patient-nurse-communication-prevent-life-threatening-complication
Our PCORI Objectives
• 1) Enable patients to make informed decisions about their preventive care by improving the quality of patient-nurse communication about the harms of VTE and benefits of VTE prophylaxis
• 2) Empower patients to take an active role in their VTE preventive care
• 3) Identify and facilitate active engagement of patients who are not administered doses of VTE prophylaxis using a real-time escalating alert
http://www.pcori.org/research-in-action/improving-patient-nurse-communication-prevent-life-threatening-complication
Our PCORICollaborators / Key Stakeholders
Patient and Family Advisory Council
http://www.pcori.org/research-in-action/improving-patient-nurse-communication-prevent-life-threatening-complication
PCORI Website “Research in Action”
http://on.wsj.com/1M18Aqu
Does Nurse Education Improve VTE Prophylaxis administration?Results from a Cluster Randomized Trial
@elliotthaut
Lau, PLoS ONE 2017
Methods
• Partnered with Central Nursing Education to build two educational programs in the MyLearning platform
• Static : Linear static education to cover point-by-point general concepts
Lau, PLoS ONE 2017
Static PowerPoint Slides With Voice Over
Lau, PLoS ONE 2017
Methods
• Partnered with Central Nursing Education to build two educational programs in the MyLearning platform
• Static: Linear static education to cover point-by-point general concepts
• Dynamic: Learner-centric interactive scenario-based dynamic education
Lau, PLoS ONE 2017
Learner centric scenario based
Methods
• Cluster Randomized Trial– 10 surgery floors– 11 medicine floors– All nurses on a specific floor were assigned either
Static or Dynamic Education• Administered satisfaction survey to compare
perceptions of education delivery after completions
• Primary Outcome - Dose Administration
Lau, PLoS ONE 2017
Nurse Education TrialPrimary Outcome- Dose Administration
• Overall, non-administration improved significantly following education
• 12.4% vs. 11.1% (p=0.002)
• Conditional OR 0.87, 95% CI (0.80-0.95)
Lau, PLoS ONE 2017
Nurse Education Trial
89.0%
82.0%
67.8%
58.8%
78.8%
94.0%*
88.8%*
78.1%*80.9%*
90.3%*
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
This course directlyapplies to my
practice
This course will helpme to communicate
better about theimportance of VTE to
my patients
I enjoyed thislearning intervention
I found this courseengaging
This course providedthe right level ofinformation and
resources
Static
Dynamic
Lau, PLoS ONE 2017
Kirkpatrick’s Learning Evaluation Theory
← They like it
← Module completion
← VTE events
← Missed doses
What VTE Education Do Patients Really Want?Results from a Delphi Survey
@elliotthaut
Modified Delphi Method
• Iterative process involving surveys, feedback and revisions
• Engaged patients and family members• Recruited via email and/or social media
(websites, Facebook, Twitter) through respective organizations
• > 400 respondents
Popoola, PLoS ONE 2016
What Do Patients Want?
Popoola, PLoS ONE 2016
What Do Patients Want?
Patient VTEEducation Bundle
@elliotthaut
What Do Patients Want?Paper Form (2-pages)
They spoke, we listened
• www.hopkinsmedicine.org/armstrong/bloodclots
Easy to Find in Hopkins Policies Online (HPO)
• Top of the list when searching– “VTE”– “DVT”– “PE”– “Blood Clots”
Multiple Languages &Large Font
• Patients wanted- 10 minute video- Physicians, nurses and patients talking
• Screened for JHH PFAC- Changes based on group feedback
They spoke, we listened
What Do Patients Want?Video
http://bit.ly/bloodclots
http://bit.ly/bloodclotsVideo
Easy to Find in Public DomainOur VTE Prevention Website
• www.hopkinsmedicine.org/armstrong/bloodclots
• Real time alert of dose non-administration from POE system via pager/email
• Patient education bundle– Targeted education– Direct one-on-one discussion with nurse– Supported by paper handout and/or video
• Prospective Cohort Study– April 2015 thru December 2015 (8 months)
What Do Patients Want?Patient Education Intervention Project
Acknowledgements
Changing Practice is a Team Effort
@elliotthaut
CDC Healthcare-Associated VTE Prevention Challenge Champions
Research Collaborators
• Johns Hopkins VTE Collaborative• Streiff, Hobson, Kraus, Lau, Shermock,
Shaffer, Shihab, Carolan, Zeidan, Popoola, Aboyage, Owodunni, Florecki, Welsh
• Armstrong Institute• Pronovost, Berenholtz, Demski, Holzmueller,
Michtalik
Collaborators from Surgery
• Division of Acute Care Surgery• Efron, Haider, Stevens, Chi, Rushing, Velopulos,
Cornwell, Schneider, Jones, Sakran, Mankayan
• Other Surgical Divisions/Departments• Colorectal, Surg Onc, Vascular, Pediatrics,
Transplant, Urology, Ortho, Neurosurgery
• Other Surgical Faculty• Gearhart, Wick, Efron, Safar, Lidor, Pawlik, Weiss,
Wolfgang, Freischlag, Black, Abdullah, Stewart, Colombani, Segev
Streiff, J Hosp Med 2016
VTE and Trainee Mentoring
• 10 MPH student capstone projects• 4 full-time post-doctoral research fellows• 6 clinical trauma surgery fellows• 3 clinical hematology fellows• 1 med student full-time research year• 1 surgical resident full-time research year• 1 human factors engineer post-doctoral• 5 pharmacy residents
Trainees
• Surgery Residents• Weiss, Hayanga, VanArendonk, Howley,
Kodadek, Arnaoutakis, Poruk, Beaulieu, Ellison• Trauma/Acute Care Surgery Fellows
• Garcia, Velopulos, Koenig, Kieninger, Leeper, Feinman, Yanagawa, Dultz, Kent
• Medical Students• Dat, Boelig, JohnBull, Farrow, Ray-Mazumder
• Pharmacy Residents• Elder, Newman, Wong, Piechowski
Bloomberg JHSPH Trainees / Collaborators
• JHSPH students• Pierce, Kardooni, Kraenzlin, Rosenberg,
Aboagye, Shrestha, Lucas, Nastasi, etc.• JHSPH faculty
• MacKenzie, Yenokyan, Sugar, Diener-West• Evidence Based Practice Center
• Segal, Singh, Brotman, Kebede
@elliotthaut (Twitter)[email protected] (email)
• Hopkins VTE Website (with paper forms)– http://www.Hopkinsmedicine.org/Armstrong/bloodclots
• Patient Education Video– http://bit.ly/bloodclots
• PCORI Research in Action– http://www.pcori.org/research-in-action/improving-
patient-nurse-communication-prevent-life-threatening-complication